Garden State Investment Advisory Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Garden State Investment Advisory Services's XBI Position: Q1 2026 in Review
Garden State Investment Advisory Services increased its State Street SPDR S&P Biotech ETF (XBI) stake by 86% in Q1 2026, buying an estimated $178K and bringing the position to 3,085 shares worth $394K. The position accounts for 0.09% of the portfolio, ranked #181.
Garden State Investment Advisory Services first reported a position in XBI in Q4 2022 and has held it in 5 quarters since. The position peaked at $592K in Q1 2023. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Garden State Investment Advisory Services held 3,085 shares of State Street SPDR S&P Biotech ETF worth $394K as of Q1 2026.
- Garden State Investment Advisory Services bought 1,425 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $178K.
- State Street SPDR S&P Biotech ETF made up 0.09% of Garden State Investment Advisory Services's portfolio in Q1 2026, its #181 holding.
- Garden State Investment Advisory Services first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and has held it in 5 quarters since.
- Garden State Investment Advisory Services's State Street SPDR S&P Biotech ETF position peaked at $592K in Q1 2023.
- 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Garden State Investment Advisory Services's 13F filing for Q1 2026, filed 14 May 2026.